Copyright © 2005, European Society of Cardiology
PGC-1
regulates the mitochondrial antioxidant defense system in vascular endothelial cells
aCentro de Investigaciones Biológicas (Consejo Superior de Investigaciones Científicas), Ramiro de Maeztu, 9 28040, Madrid, Spain
bCentro Nacional de Investigaciones Cardiovasculares (Instituto de Salud Carlos III), Ronda de Poniente, 5 Tres Cantos 28760, Madrid, Spain
cInstituto "Reina Sofía de Investigaciones Nefrológicas", Spain
* Corresponding authors. Centro Nacional de Investigaciones Cardiovasculares (Instituto de Salud Carlos III), Ronda de Poniente, 5 Tres Cantos 28760-Madrid, Spain. Tel.: +34 918061880x1140; fax: +34 918035258. Email address: mmonsalve{at}cnic.es
Objective: Mitochondrial production of oxidants contributes to a variety of pathological conditions including the vascular complications of diabetes, neurodegenerative diseases, and cellular senescence. We postulated that a transcriptional coactivator, peroxisome proliferator activated receptor-
coactivator 1
(PGC-1
), a major regulator of oxidative metabolism and mitochondrial biogenesis, could be involved in the transcriptional regulation of the mitochondrial antioxidant defense system in vascular endothelial cells.
Methods and results: We show that PGC-1
is present in human, bovine, and mouse endothelial cells and positively modulates the expression of the mitochondrial detoxification system. Endothelial cells that overexpress PGC-1
show reduced accumulation of reactive oxygen species (ROS), increased mitochondrial membrane potential, and reduced apoptotic cell death both in basal and oxidative stress conditions. Downregulation of PGC-1
levels by siRNA reduces the expression of mitochondrial detoxification proteins.
Conclusions: These results unveil a novel regulatory pathway that links mitochondrial activity and mitochondrial oxidative stress protective systems. In addition, they suggest that PGC-1
could play a crucial protective role in vascular complications of diabetes, where the mitochondrial metabolism of glucose has been shown to result in oxidative stress and vascular endothelial cell dysfunction.
KEYWORDS PGC-1
; Endothelium; Oxidative stress; Mitochondria; Glucose
Time for primary review 28 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. J. Lehman, S. Boudina, N. H. Banke, N. Sambandam, X. Han, D. M. Young, T. C. Leone, R. W. Gross, E. D. Lewandowski, E. D. Abel, et al. The transcriptional coactivator PGC-1{alpha} is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H185 - H196. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanaka, L. M. Aleksunes, R. L. Yeager, M. A. Gyamfi, N. Esterly, G. L. Guo, and C. D. Klaassen NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 655 - 664. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Leick, J. F. P. Wojtaszewski, S. T. Johansen, K. Kiilerich, G. Comes, Y. Hellsten, J. Hidalgo, and H. Pilegaard PGC-1{alpha} is not mandatory for exercise- and training-induced adaptive gene responses in mouse skeletal muscle Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E463 - E474. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Olson, M. B. Hock, S. Ekholm-Reed, J. A. Wohlschlegel, K. K. Dev, A. Kralli, and S. I. Reed SCFCdc4 acts antagonistically to the PGC-1{alpha} transcriptional coactivator by targeting it for ubiquitin-mediated proteolysis Genes & Dev., January 15, 2008; 22(2): 252 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Andrulionyte, T. Kuulasmaa, J.-L. Chiasson, M. Laakso, and for the STOP-NIDDM Study Group Single Nucleotide Polymorphisms of the Peroxisome Proliferator-Activated Receptor-{alpha} Gene (PPARA) Influence the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The STOP-NIDDM Trial Diabetes, April 1, 2007; 56(4): 1181 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Borniquel, I. Valle, S. Cadenas, S. Lamas, and M. Monsalve Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1{alpha} FASEB J, September 1, 2006; 20(11): 1889 - 1891. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Iglseder, H. Oberkofler, T. K. Felder, K. Klein, B. Paulweber, F. Krempler, D. A. Tregouet, and W. Patsch Associations of PPARGC1A Haplotypes With Plaque Score but Not With Intima-Media Thickness of Carotid Arteries in Middle-Aged Subjects Stroke, September 1, 2006; 37(9): 2260 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rodriguez-Calvo, M. Jove, T. Coll, A. Camins, R. M. Sanchez, M. Alegret, M. Merlos, M. Pallas, J. C. Laguna, and M. Vazquez-Carrera PGC-1{beta} Down-Regulation Is Associated With Reduced ERR{alpha} Activity and MCAD Expression in Skeletal Muscle of Senescence-Accelerated Mice. J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2006; 61(8): 773 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Andrulionyte, P. Peltola, J.-L. Chiasson, M. Laakso, and for the STOP-NIDDM Study Group Single Nucleotide Polymorphisms of PPARD in Combination With the Gly482Ser Substitution of PGC-1A and the Pro12Ala Substitution of PPARG2 Predict the Conversion From Impaired Glucose Tolerance to Type 2 Diabetes: The STOP-NIDDM Trial. Diabetes, July 1, 2006; 55(7): 2148 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Corton and H. M. Brown-Borg Peroxisome Proliferator-Activated Receptor {gamma} Coactivator 1 in Caloric Restriction and Other Models of Longevity J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1494 - 1509. [Abstract] [Full Text] [PDF] |
||||







